Phase 0 trials: expediting the development of chemoprevention agents.
about
New concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkersNrf2-dependent suppression of azoxymethane/dextran sulfate sodium-induced colon carcinogenesis by the cinnamon-derived dietary factor cinnamaldehyde.Early-phase development of cancer prevention agents: challenges and opportunitiesCancer chemoprevention: a rapidly evolving field.
P2860
Phase 0 trials: expediting the development of chemoprevention agents.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phase 0 trials: expediting the development of chemoprevention agents.
@ast
Phase 0 trials: expediting the development of chemoprevention agents.
@en
Phase 0 trials: expediting the development of chemoprevention agents.
@nl
type
label
Phase 0 trials: expediting the development of chemoprevention agents.
@ast
Phase 0 trials: expediting the development of chemoprevention agents.
@en
Phase 0 trials: expediting the development of chemoprevention agents.
@nl
prefLabel
Phase 0 trials: expediting the development of chemoprevention agents.
@ast
Phase 0 trials: expediting the development of chemoprevention agents.
@en
Phase 0 trials: expediting the development of chemoprevention agents.
@nl
P2860
P1476
Phase 0 trials: expediting the development of chemoprevention agents.
@en
P2093
James H Doroshow
Shivaani Kummar
P2860
P304
P356
10.1158/1940-6207.CAPR-11-0013
P577
2011-03-01T00:00:00Z